About: Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $0.88 (-0.87%)
CRDL NASDAQ Cardiol Therapeutics Inc Class A
Cardiol Therapeutics Inc Class A share price
Atividade de preço de CRDL
Último preço
$ 0,880
Variação (24h)
-0,01 USD (0,87%)
Volume
59.21K
Volume (média 4 sem.)
-
Abertura
$ 0,88
Variação do dia
$ 0,88 - $ 0,90
Fechamento anterior
$ 0,88
Último negócio
20 Nov, 2:38 pm GMT+0
Atrasado
20 Nov, 2:38 pm GMT+0
CRDL price performance
Atrasado
20 Nov, 2:38 pm GMT+0
CRDL details
quote.marketSignals